Healthy Japanese women between the ages of 30 and 59
Conditions
Interventions
Continuous use every morning and evening for 8 weeks
Sponsors
Medical Corporation Hokubukai Utsukushigaoka Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Healthy Japanese women aged 30 to 59 at the time of screening test 2. A person who has received sufficient explanation about the test product as well as the purpose and content of this research, and then given written consent to participate in the research voluntarily.
Exclusion criteria
Exclusion criteria: 1. Persons who have factors that affect the evaluation at the evaluation site including atopic dermatitis, trauma, burns, inflammation, acne, warts, etc. 2. Those who go to the hospital for treatment of an affected area on the face 3. Those who have a history of allergies to cosmetics 4. Those who are receiving hormone replacement therapy 5. Those who are pregnant or breastfeeding, or those who will not use proper birth control because of wishing to become pregnant during the period from the time of giving consent to the end of the study. 6. Those who have received cosmetic medicine that affects the evaluation site, or those who plan to receive it during the research period 7. Those who have undergone special skin care treatment (facial treatment, etc.) that affects the evaluation site within 4 weeks before the start of application of the test product, or those who are planning to receive it during the research period. 8. Those who received the test product in other clinical trials within 4 weeks before the start of application of the test product, or those who plan to participate in other trial during the research period 9. Those who are judged to be ineligible by the principal investigator or investigators with other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin findings(Medical examination) : 0-8 weeks Adverse events : 0-8 weeks Subjective symptoms(Questionnaire, life diary) : 8 weeks | — |
Countries
Japan
Contacts
Public ContactTakuya Matsuda
Medical Corporation Hokubukai Utsukushigaoka Hospital Center for Clinical Pharmacology
Outcome results
None listed